Pyridostigmine differs from neostigmine in that
Rationale:
Pyridostigmine is longer acting than neostigmine.
Pyridostigmine has a prolonged duration of action compared to neostigmine, making it more suitable for managing conditions like myasthenia gravis. This extended action allows for less frequent dosing, improving patient adherence and overall treatment effectiveness in controlling symptoms.
A: More potent orally. Pyridostigmine’s oral potency does not surpass that of neostigmine, which is similarly effective when given by mouth, thus not distinguishing the two.
C: Less muscarinic side effects. Both drugs can induce muscarinic side effects; pyridostigmine does not significantly reduce these effects compared to neostigmine, so this option is misleading.
D: All of the above. This option implies that all statements are true, yet only the longer acting characteristic of pyridostigmine is accurate, invalidating the overall claim.
A 33-year-old patient with asthma is being treated with nedocromil. Which of the following is the major action of nedocromil?
Rationale:
B: Block of mediator release from mast cells. Nedocromil primarily functions as a mast cell stabilizer, inhibiting the release of inflammatory mediators, thereby mitigating bronchoconstriction and improving asthma symptoms effectively.
A: Block of calcium channels in lymphocytes. Nedocromil does not primarily target calcium channels; its action focuses on stabilizing mast cells and preventing the release of pro-inflammatory substances.
C: Smooth muscle relaxation in the bronchi. This drug does not induce direct relaxation of bronchial smooth muscles; its mechanism centers on blocking mediator release, rather than acting as a bronchodilator.
D: Stimulation of cortisol release by the adrenals. Nedocromil does not influence adrenal function or cortisol production; its role in asthma management revolves around stabilizing mast cells and reducing inflammation.
The physician has ordered a dry powder inhaler for a patient that is being discharged. The patient has never used an inhaler before. Which of the following instructions is correct for using a dry powder inhaler?
Rationale:
C: Inhale rapidly for 1-2 seconds. This instruction is correct because a dry powder inhaler requires a strong, quick inhalation to effectively disperse the medication into fine particles for optimal delivery to the lungs.
A: Blow slowly into the device. This technique does not apply to dry powder inhalers, as they rely on the patient’s inhalation rather than exhalation to activate the medication.
B: Hold the device vertically after loading. While correct positioning is important, it is not the primary instructional focus for effective medication delivery, which emphasizes the inhalation technique.
D: Breathe normally in and out of the device. This approach would not ensure adequate medication delivery, as dry powder inhalers necessitate a forceful inhalation to ensure the medication is properly inhaled.
The following drugs may induce bronchospasm EXCEPT:
Rationale:
D: Ephedrine is a bronchodilator that relaxes airway smooth muscles, making it effective in treating conditions like asthma and bronchospasm, thus not inducing bronchospasm itself.
A: Pilocarpine stimulates muscarinic receptors, leading to increased airway resistance and potential bronchospasm, particularly in sensitive individuals.
B: Acetylcholine activates cholinergic pathways, promoting bronchoconstriction and increasing mucus secretion, which can result in bronchospasm.
C: Aspirin may trigger bronchospasm in asthmatic patients through the inhibition of cyclooxygenase, leading to an imbalance of leukotrienes and other mediators.
Acute exacerbations of asthma can be triggered by all of the following except
Rationale:
Acute exacerbations of asthma can be triggered by all of the following except hot, dry weather.
Hot, dry weather typically does not provoke asthma symptoms, as humidity often increases allergens and irritants in the air, while dry conditions may not influence airway hyperresponsiveness.
A: Bacterial or viral pneumonia can lead to increased inflammation and mucus production in the airways, exacerbating asthma symptoms significantly.
B: Hypersensitivity reaction to penicillin can provoke an immune response, leading to bronchoconstriction and worsening asthma control in sensitive individuals.
C: Discontinuation of asthma medication often results in reduced control of asthma, causing increased susceptibility to exacerbations from various triggers.
Which of the following expectorants acts both directly on the airway mucosa as well as reflexly?
Rationale:
A: Potassium iodide acts both directly on the airway mucosa and reflexly, enhancing mucous clearance by stimulating respiratory secretions and facilitating expectoration, thus improving respiratory function and alleviating congestion.
B: Guaiphenesin primarily functions by reducing mucus viscosity, promoting expectoration indirectly through its effects on mucus secretions rather than acting directly on the airway mucosa or reflexively.
C: Terpin hydrate acts as an expectorant, but its mechanism is largely limited to thinning mucus and does not exert both direct and reflex actions on the airway mucosa.
D: Bromhexine primarily enhances the production of less viscous mucus and improves expectoration, focusing on mucus properties rather than having a dual action on the airway mucosa.
Which of the following has overdose toxicity that includes insomnia, arrhythmias, and convulsions?
Rationale:
Aminophylline overdose toxicity includes insomnia, arrhythmias, and convulsions due to its action as a phosphodiesterase inhibitor, which can lead to increased levels of cyclic AMP, affecting cardiac and neurological function.
B: Cromolyn This medication primarily acts as a mast cell stabilizer and does not exhibit significant central nervous system or cardiovascular toxicity associated with overdose, making it an unlikely candidate.
C: Epinephrine While it can induce arrhythmias, it is associated more with hypertension and tachycardia rather than insomnia or convulsions specifically linked to overdose scenarios.
D: Ipratropium This anticholinergic agent is primarily used for respiratory issues and does not produce severe central nervous system effects or the specific overdose symptoms mentioned in the question.
A 10-year-old child has severe asthma and was hospitalized 5 times between the ages of 7 and 9. He is now receiving outpatient medications that have greatly reduced the frequency of severe attacks. Which of the following is most likely to interfere with growth when used daily over long periods for severe asthma?
Rationale:
Daily use of prednisone by mouth is most likely to interfere with growth when used over long periods for severe asthma. Long-term corticosteroid therapy can inhibit growth by affecting bone metabolism and reducing growth hormone levels, making it a significant concern for pediatric patients managing chronic asthma.
A: Abuterol by aerosol stimulates beta-2 adrenergic receptors, providing bronchodilation without substantial long-term effects on growth, making it safer for children with asthma management.
B: Tiotropium by aerosol, a long-acting anticholinergic, primarily aids in bronchodilation and does not have a significant impact on growth, making it suitable for long-term asthma control.
C: Cromolyn by inhaler stabilizes mast cells and prevents asthma symptoms without systemic effects on growth, thereby posing minimal risk for children needing ongoing asthma treatment.
A 50-year-old male patient was just admitted for asthma. After obtaining the patient's medication history, which of the following would you consider least important?
Rationale:
C: Use of generic vs. brand name medications is least important in this context. The patient's understanding of their asthma management, including proper techniques and medication usage, is far more critical for effective treatment and adherence.
A: Self-administration techniques play a crucial role in ensuring the patient can effectively manage their asthma, significantly impacting their health outcomes and preventing exacerbations.
B: Frequency of rescue inhaler usage indicates the severity and control of the patient's asthma, providing essential information for adjusting treatment plans and improving overall respiratory health.
D: Patient understanding of controllers vs. relievers is vital for proper asthma management, as it influences adherence to therapy and ensures the patient uses medications appropriately for their condition.
Moniliasis of mouth is a complication of inhalation of:
Rationale:
Moniliasis of mouth is a complication of inhalation of Beclomethasone. This corticosteroid can disrupt the natural balance of oral flora, leading to an overgrowth of Candida species and subsequent oral thrush, known as moniliasis.
B: Formoterol This long-acting beta-agonist primarily relaxes airway muscles and does not significantly alter oral flora, thus not typically contributing to moniliasis development.
C: Ipratropium This anticholinergic agent primarily prevents bronchoconstriction and lacks the immunosuppressive effects associated with corticosteroids, making it unlikely to cause oral thrush.
D: Nedocromil As a mast cell stabilizer, it does not impact the immune response directly and is not linked to oral fungal infections like moniliasis.
Side effects of salbutamol include which of the following:
Rationale:
Tachycardia. Salbutamol, a bronchodilator, can stimulate the heart, leading to increased heart rate. This side effect occurs due to its action on beta-adrenergic receptors, which can enhance sympathetic nervous system activity.
B: Bradycardia. Salbutamol typically does not slow the heart rate; instead, it accelerates it, countering the physiological response that results in bradycardia.
C: Vomiting. While gastrointestinal disturbances can occur with various medications, salbutamol primarily influences respiratory pathways and does not commonly induce vomiting as a side effect.
D: CNS depression. Salbutamol primarily acts on the respiratory system, and its mechanism does not support central nervous system depression, which is generally associated with sedative or narcotic agents.
Hâ‚ antihistaminics are beneficial in
Rationale:
H1 antihistaminics are beneficial in certain type I allergic reactions only. This answer is correct because H1 antihistaminics specifically target histamine receptors involved in immediate hypersensitivity reactions, effectively alleviating symptoms associated with type I allergies such as hay fever and certain food allergies.
A: All types of allergic disorders H1 antihistaminics do not address non-immediate allergic reactions, making their effectiveness limited to specific allergies rather than encompassing all allergic disorders universally.
C: Anaphylactic shock H1 antihistaminics are not suitable for treating anaphylactic shock, which requires immediate epinephrine administration to counteract life-threatening symptoms, rather than just histamine blockade.
D: Bronchial asthma H1 antihistaminics do not treat bronchial asthma effectively, as asthma is primarily mediated by leukotrienes and other inflammatory pathways that antihistamines do not influence.
A COPD patient is being discharged and the doctor wants to prescribe a controller-type bronchodilator for home use. Which of the following would you recommend?
Rationale:
D: Brovana is the appropriate choice as it contains arformoterol, a long-acting bronchodilator specifically indicated for COPD management. Its prolonged effect helps maintain open airways, improving overall respiratory function for patients at home.
A: Albuterol delivers short-term relief, making it unsuitable as a controller medication for COPD patients requiring consistent bronchodilation to manage chronic symptoms effectively.
B: Levalbuterol is a short-acting bronchodilator, similar to albuterol, providing temporary relief rather than the long-term control necessary for managing COPD symptoms over time.
C: Metaproterenol, while a bronchodilator, is less commonly used today and does not provide the sustained action required for effective COPD management compared to long-acting options like Brovana.
A patient with fluid overload was just given a dose of furosemide via IV. Afterwards, the patient displayed an arrhythmia on the EKG that was not there before the dose was given. Which of the following would you recommend at this time?
Rationale:
Check the patient's potassium level.
Administering furosemide can lead to electrolyte imbalances, particularly hypokalemia, which may cause arrhythmias. Evaluating potassium levels is crucial to address this potential complication and manage the patient's condition effectively.
A: Defibrillate the patient. Immediate defibrillation is only necessary for life-threatening arrhythmias, and further assessment is needed before taking such drastic measures.
B: Administer another dose of furosemide. Giving more furosemide could exacerbate electrolyte imbalances and worsen the arrhythmia without addressing the underlying cause.
C: Administer a dose of epinephrine. Epinephrine is not indicated for arrhythmias caused by electrolyte disturbances and may complicate the patient's situation without resolving the immediate issue.
While assessing a 72-year-old postoperative patient, you noted distinct wheezing in both lung fields. Which of the following would recommend for this condition?
Rationale:
Give the patient a bronchodilator. Bronchodilators are effective in alleviating wheezing by relaxing bronchial muscles, thereby dilating airways, which is essential for improving airflow and oxygenation in patients with obstructive airway conditions.
B: Administer incentive spirometry. While it promotes lung expansion and prevents atelectasis, it does not directly address the bronchospasm causing wheezing, making it less suitable for immediate relief.
C: Give the patient a mucolytic agent. Mucolytics help thin mucus but do not resolve the underlying bronchospasm associated with wheezing, thus failing to provide the necessary immediate relief.
D: Administer chest physiotherapy. This technique aids in clearing secretions but does not target the bronchial constriction causing wheezing, making it an inappropriate choice for this patient's condition.
While monitoring a 67-year-old patient that is receiving volume controlled SIMV, you note that the patient has bilateral wheezes upon auscultation with an increased peak pressure. Which of the following would be appropriate for this patient?
Rationale:
Administer their prescribed bronchodilators. Bronchodilators are essential in managing wheezing and airway constriction, particularly in patients with respiratory distress, as they relax bronchial smooth muscles and alleviate obstructions effectively.
A: Suction the patient's airway. This action targets secretions rather than addressing the underlying wheezing, which indicates bronchospasm rather than blockage, making it an inappropriate first response.
B: Order a stat chest X-ray. Although imaging can be useful, it does not provide immediate relief for wheezing or increased peak pressure, which require prompt therapeutic intervention instead.
C: Check the cuff pressure. While important for preventing aspiration, evaluating cuff pressure does not directly address the respiratory distress caused by wheezing and increased airway resistance in this scenario.
Isoxuprine is used to treat
Rationale:
Isoxuprine is used to treat premature labor. This medication functions as a tocolytic agent, effectively relaxing the uterine muscles and helping to delay early childbirth, thus providing essential time for fetal development.
A: Asthma Isoxuprine does not target bronchial dilation or airway inflammation, which are critical in asthma management, making it unsuitable for treating this respiratory condition.
B: Severe hypotension While Isoxuprine has vascular effects, it is not a primary treatment for severe hypotension, which requires other medications specifically designed to increase blood pressure effectively.
C: Nasal congestion Isoxuprine lacks the necessary decongestant properties to relieve nasal congestion, as its mechanism does not address sinus or nasal passage obstruction directly.
One of the following drugs is a useful bronchodilator but not acting via stimulation of Beta adrenoceptors in respiratory smooth muscles:
Rationale:
D: Theophyllin acts as a bronchodilator through phosphodiesterase inhibition, leading to increased cyclic AMP levels in airway smooth muscle, unlike other options that primarily stimulate Beta adrenoceptors for bronchodilation.
A: Adrenaline stimulates Beta adrenoceptors, which directly promotes bronchodilation in respiratory smooth muscles, making it reliant on this mechanism for its therapeutic effects.
B: Isoprenaline predominantly works by activating Beta adrenoceptors, enhancing bronchodilation through direct stimulation, thus fulfilling its role in respiratory therapies based on this action.
C: Salbutamol is a selective Beta-2 agonist that induces bronchodilation by targeting Beta adrenoceptors specifically, thereby not fitting the criteria of non-Beta adrenoceptor action.
You are called to administer acetylcysteine to a 66-year-old female patient. This drug can be helpful in treating which of the following conditions?
Rationale:
Acetylcysteine can be helpful in treating mucous plugs. This medication acts as a mucolytic agent, breaking down mucus and facilitating its clearance from the airways, particularly in patients with compromised respiratory function.
A: Bronchospasm This condition involves the tightening of muscles around the airways, which acetylcysteine does not target or alleviate directly.
C: Pleural effusion Acetylcysteine does not address fluid accumulation in the pleural space, making it ineffective for this condition.
D: Pulmonary hypertension The drug does not have a role in managing elevated blood pressure in the pulmonary arteries, which requires different therapeutic approaches.
A patient in the ICU is receiving mechanical ventilation but appears to be breathing asynchronously with the ventilator. Which of the following medications would you recommend?
Rationale:
Benzodiazepines like Midazolam (Versed) are recommended to manage anxiety and agitation in patients on mechanical ventilation, helping synchronize the patient's breathing with the ventilator for better respiratory support.
A: Fluoxetine (Prozac) This selective serotonin reuptake inhibitor primarily treats depression and anxiety, lacking immediate sedative effects necessary for managing asynchronous breathing in critically ill patients.
C: Dextroamphetamine (Dexedrine) This stimulant increases alertness and can exacerbate restlessness, which is counterproductive for patients requiring mechanical ventilation and proper respiratory coordination.
D: Cisatracurium (Nimbex) While a neuromuscular blocker, it may paralyze the patient entirely, eliminating voluntary breathing, which is not suitable for managing asynchronous ventilation without close monitoring.
Which of the following is a nauseate expectorant:
Rationale:
Tincture Ipecacuanaha is a nauseate expectorant. This option stimulates the gastrointestinal tract, inducing nausea and vomiting, which helps expel mucus and phlegm from the respiratory system, enhancing expectoration effectively.
A: Acetylcholine acts as a neurotransmitter and does not function as an expectorant, lacking any properties that would facilitate mucus clearance or induce nausea effectively.
B: Pholcodine serves primarily as a cough suppressant, inhibiting the cough reflex rather than promoting expectoration, thus not fitting the definition of a nauseate expectorant.
C: Bromhexine is a mucolytic agent that aids in thinning mucus but does not induce nausea or vomiting, making it unsuitable for classification as a nauseate expectorant.
The National Institutes of Health (NIH) guidelines for the treatment of asthma recommended institution of routine inhaled corticosteroids when patients are classified as having greater than or equal to which type of asthma?
Rationale:
Inhaled corticosteroids should be initiated for patients classified as having mild persistent asthma. This recommendation is based on the need to manage symptoms effectively and prevent exacerbations in individuals experiencing symptoms more than twice a week.
A: Mild intermittent Symptoms occur infrequently, typically less than twice a week, thus not warranting routine inhaled corticosteroid treatment according to NIH guidelines.
C: Moderate persistent This classification indicates daily symptoms, but routine inhaled corticosteroids are specifically recommended for mild persistent asthma as a preventive measure.
D: Severe persistent Patients with severe persistent asthma require a more aggressive treatment approach, but the guidelines specifically mention mild persistent asthma for initiating routine inhaled corticosteroids.
You are called to give an aerosolized breathing treatment with albuterol to a 41-year-old male patient. If the patient's heart rate were to increase during the treatment, that would be a result of which of the following?
Rationale:
Increased heart rate during albuterol treatment is a result of both Beta 1 and Beta 2 receptor stimulation. Beta 1 receptors primarily influence cardiac function, while Beta 2 receptors can also affect heart rate indirectly through vasodilation and reduced resistance.
A: Alpha only. Alpha receptors primarily mediate vasoconstriction and are not directly responsible for increasing heart rate during albuterol treatment.
B: Beta 1 only. While Beta 1 receptors do increase heart rate, they alone do not account for the effects of Beta 2 stimulation during treatment.
C: Beta 2 only. Beta 2 receptors primarily cause bronchial dilation, and their role in heart rate elevation is secondary and not sufficient to explain the increase on their own.
While prescribing the conventional H₠‚ antihistaminics the patient should be advised to avoid
Rationale:
Driving motor vehicles. Conventional Hâ‚ antihistaminics can cause drowsiness and impair cognitive function, making it unsafe for patients to operate vehicles. This warning is crucial for ensuring the patient's safety and that of others on the road.
B: Consuming processed cheese. There is no direct link between processed cheese and the effects of antihistaminics, making this advice irrelevant to the medication’s side effects.
C: Strenuous physical exertion. While caution is advised, strenuous activity isn't directly impacted by antihistaminic use, so this guidance lacks a compelling basis in the context provided.
D: All of the above. This option implies that all listed activities must be avoided, but only driving is specifically contraindicated due to its clear risks associated with drowsiness from the medication.
The common and dose related side effect of salbutamol is
Rationale:
Muscle tremor is a common and dose-related side effect of salbutamol. This side effect occurs due to the stimulation of beta-2 adrenergic receptors in skeletal muscle, leading to increased muscle activity and involuntary contractions, particularly at higher doses.
A: Rise in blood pressure. While salbutamol can affect cardiovascular function, it primarily leads to vasodilation rather than a consistent rise in blood pressure.
C: Hyperglycaemia. Although salbutamol can influence glucose metabolism, hyperglycaemia is not a typical or common dose-related side effect associated with its use.
D: Central nervous system stimulation. Salbutamol primarily acts on peripheral receptors; central nervous system stimulation is not a primary or frequent side effect of this medication.
Ipratropium bromide:
Rationale:
Ipratropium bromide causes bronchodilatation because of its antagonistic effects at the cholinergic M2/M3 receptors. This mechanism leads to reduced bronchoconstriction, making it effective for patients with respiratory conditions, such as asthma or COPD.
A: Is administered intravenously. Ipratropium bromide is typically delivered via inhalation, not intravenously, which is vital for its localized effect in the lungs.
C: Has a more rapid onset of bronchodilatation than beta agonists. Beta agonists generally provide a quicker bronchodilatory response, making them preferred for acute bronchospasm situations.
D: Has a bitter taste. While some patients may experience a bitter taste, this characteristic does not define its pharmacological action or therapeutic efficacy in treating respiratory conditions.
A 64-year-old male patient is receiving an aerosol treatment with acetylcysteine and hypertonic saline via a small volume nebulizer. After only a few minutes, the patient suddenly becomes dyspneic. Which of the following is the most likely cause of this problem is?
Rationale:
Bronchospasm is the most likely cause of the patient's sudden dyspnea during aerosol treatment. Acetylcysteine and hypertonic saline can irritate airways, potentially triggering bronchospasm, especially in sensitive patients.
A: Hypercapnia Elevated carbon dioxide levels typically lead to respiratory distress over time, not acutely in the context of nebulizer treatments, making this an unlikely cause for sudden dyspnea.
C: Hypotension This condition usually manifests with symptoms like dizziness or fainting, rather than immediate respiratory distress, thus not correlating with the sudden onset of dyspnea observed here.
D: Fluid overload While possible in certain contexts, fluid overload usually results in gradual respiratory issues and would not likely cause an immediate, acute episode of dyspnea during nebulization.
To be a useful inhaled glucocorticoid the drug should have
Rationale:
To be a useful inhaled glucocorticoid, the drug should have low oral bioavailability. This characteristic minimizes systemic side effects while maximizing the local anti-inflammatory effect in the lungs.
A: High oral bioavailability leads to increased systemic exposure, which can result in significant side effects and diminish the targeted therapeutic effect in the respiratory system.
C: Additional bronchodilator activity is not essential for glucocorticoids; their primary function is to reduce inflammation rather than directly dilate the airways.
D: Prodrug character is not a requirement for inhaled glucocorticoids; their efficacy primarily relies on their active form’s direct action on inflammatory pathways in respiratory tissues.
Fluticasone by inhalation is useful in long-term control of bronchial asthma by acting as:
Rationale:
Fluticasone by inhalation is useful in long-term control of bronchial asthma by acting as an anti-inflammatory corticosteroid. This medication reduces inflammation in the airways, leading to decreased mucus production and improved airflow, thereby effectively managing asthma symptoms over time.
A: Anti-leukotriene This option relates to medications that block leukotrienes, which are involved in inflammatory responses, but fluticasone specifically targets inflammation through corticosteroid action.
B: Anti-histamine This category addresses allergy-related symptoms by blocking histamine, but it does not focus on reducing airway inflammation, which is crucial in asthma control.
D: Mast cell stabilizer This type of medication prevents mast cell degranulation and release of inflammatory mediators, whereas fluticasone directly suppresses overall inflammation in the bronchial passages.
Pulmonary eosinophilia is caused by the following drugs:
Rationale:
Pulmonary eosinophilia is caused by nitrofurantoin. This drug is known to provoke hypersensitivity reactions, which can lead to an increase in eosinophils in the lungs, resulting in pulmonary eosinophilia.
A: Methysergide This medication primarily treats migraines and does not typically induce pulmonary eosinophilia, as its side effects are largely related to vascular and gastrointestinal issues.
B: Aspirin Aspirin is commonly associated with gastrointestinal and bleeding complications, but it does not have a significant link to inducing pulmonary eosinophilia in patients.
D: Carmustine (BCNU) Although Carmustine is a chemotherapeutic agent, its side effects are predominantly hematologic and do not include an association with pulmonary eosinophilia.
Pyridostigmine differs from neostigmine in that
Rationale:
Pyridostigmine differs from neostigmine in that it has a longer duration of action.
This extended action allows pyridostigmine to be more effective for managing conditions like myasthenia gravis, providing sustained symptom relief compared to neostigmine, which has a shorter duration and may require more frequent dosing.
A: More potent orally. Pyridostigmine is not necessarily more potent orally; its effectiveness is related to its longer duration rather than oral potency.
C: Less muscarinic side effects. Pyridostigmine does not inherently have fewer muscarinic side effects compared to neostigmine; both can produce similar side effects.
D: All of the above. While pyridostigmine is longer acting, it does not demonstrate all the attributes listed, making this option inaccurate overall.
A 33-year-old patient with asthma is being treated with nedocromil. Which of the following is the major action of nedocromil?
Rationale:
Nedocromil's major action is to block mediator release from mast cells. This function is crucial as it helps prevent the release of inflammatory substances that trigger asthma symptoms, thereby improving respiratory function and reducing airway hyperreactivity.
A: Block of calcium channels in lymphocytes. This action does not pertain to nedocromil's primary mechanism, which focuses on mast cell stabilization rather than affecting calcium signaling in lymphocytes.
C: Smooth muscle relaxation in the bronchi. While bronchodilation is essential in asthma management, nedocromil primarily works by preventing mediator release rather than directly inducing muscle relaxation in bronchial tissues.
D: Stimulation of cortisol release by the adrenals. Nedocromil does not influence adrenal function or cortisol levels; its role is centered on mast cell stabilization, not hormone modulation.
The physician has ordered a dry powder inhaler for a patient that is being discharged. The patient has never used an inhaler before. Which of the following instructions is correct for using a dry powder inhaler?
Rationale:
Inhale rapidly for 1-2 seconds. This method ensures that the dry powder medication is effectively delivered deep into the lungs, maximizing its therapeutic effects, especially for patients unfamiliar with inhalation techniques.
A: Blow slowly into the device. This approach would not facilitate proper medication delivery, as a gentle exhalation can cause the powder to disperse rather than concentrate for inhalation.
B: Hold the device vertically after loading. The orientation affects the inhalation process; however, positioning it correctly does not address the crucial technique of inhalation needed for optimal medication dispersal.
D: Breathe normally in and out of the device. Normal breathing lacks the force necessary to draw the powder into the lungs, thereby reducing the effectiveness of the inhaler’s medication delivery.
The following drugs may induce bronchospasm EXCEPT:
Rationale:
D: Ephedrine does not induce bronchospasm; instead, it acts as a bronchodilator, helping to relax bronchial muscles and open airways, making it beneficial for asthma and other respiratory conditions.
A: Pilocarpine stimulates muscarinic receptors, leading to bronchoconstriction, which can provoke bronchospasm in susceptible individuals, particularly those with asthma or chronic obstructive pulmonary disease.
B: Acetylcholine also activates muscarinic receptors, resulting in bronchoconstriction and potential bronchospasm, especially in patients with pre-existing respiratory issues or hypersensitivity.
C: Aspirin can trigger bronchospasm in individuals with aspirin-exacerbated respiratory disease (AERD), where it causes inflammatory responses that lead to airway constriction and related symptoms.
Acute exacerbations of asthma can be triggered by all of the following except
Rationale:
Hot, dry weather does not trigger acute exacerbations of asthma. Instead, asthma exacerbations are often caused by infections, allergic reactions, or the abrupt cessation of prescribed medications, which are more directly related to respiratory distress.
A: Bacterial or viral pneumonia Respiratory infections like pneumonia can significantly aggravate asthma symptoms, leading to acute exacerbations due to increased inflammation and airway constriction.
B: Hypersensitivity reaction to penicillin Allergic reactions, including those to medications like penicillin, can provoke asthma attacks by triggering an immune response that inflames the airways and restricts airflow.
C: Discontinuation of asthma medication Stopping asthma medication can leave individuals vulnerable to exacerbations, as their respiratory system may lose the protective effects of bronchodilators or anti-inflammatory treatments.
Which of the following expectorants acts both directly on the airway mucosa as well as reflexly?
Rationale:
Potassium iodide acts both directly on the airway mucosa as well as reflexly. This dual action helps to enhance mucus clearance and reduce the viscosity of secretions, making it effective in treating respiratory conditions associated with mucus buildup.
B: Guaiphenesin primarily works by reducing mucus viscosity but does not directly stimulate the airway mucosa or have a reflex action.
C: Terpin hydrate mainly serves as an expectorant through its mucolytic properties and lacks the dual action on the airway mucosa.
D: Bromhexine acts as a mucolytic agent, improving mucus clearance but does not exert both direct and reflex actions on the airway mucosa.
Which of the following has overdose toxicity that includes insomnia, arrhythmias, and convulsions?
Rationale:
Aminophylline presents overdose toxicity that includes insomnia, arrhythmias, and convulsions. This is due to its mechanism as a methylxanthine, which stimulates the central nervous system and affects cardiovascular function.
B: Cromolyn lacks significant toxicity in overdose situations, primarily functioning as a mast cell stabilizer without stimulating effects on the central nervous system or causing cardiovascular disturbances.
C: Epinephrine, while capable of causing arrhythmias, primarily leads to symptoms like anxiety and hypertension rather than insomnia or convulsions, making it less relevant in this context.
D: Ipratropium, an anticholinergic agent, is not associated with overdose toxicity symptoms such as insomnia or convulsions, focusing instead on respiratory effects without significant central nervous system impact.
A 10-year-old child has severe asthma and was hospitalized 5 times between the ages of 7 and 9. He is now receiving outpatient medications that have greatly reduced the frequency of severe attacks. Which of the following is most likely to interfere with growth when used daily over long periods for severe asthma?
Rationale:
Daily use of prednisone by mouth is most likely to interfere with growth over long periods for severe asthma. Prednisone is a corticosteroid that, when used extensively, can inhibit growth in children by affecting bone metabolism and hormone levels, making it a significant concern for long-term management in pediatric patients.
A: Abuterol by aerosol Albuterol primarily acts as a bronchodilator, providing quick relief from asthma symptoms without the long-term side effects associated with growth suppression, making it safer for continuous use.
B: Tiotropium by aerosol Tiotropium, an anticholinergic medication, primarily helps maintain open airways and does not have growth-inhibiting effects, making it less likely to interfere with a child's development.
C: Cromolyn by inhaler Cromolyn serves as a mast cell stabilizer to prevent asthma attacks and has a favorable safety profile, showing no significant impact on growth when used over extended periods.
A 50-year-old male patient was just admitted for asthma. After obtaining the patient's medication history, which of the following would you consider least important?
Rationale:
C: Use of generic vs. brand name medications. While understanding medication types is important, the distinction between generic and brand names holds less significance in immediate asthma management compared to other factors such as usage patterns and self-administration.
A: Self-administration techniques. Mastery of self-administration techniques is vital for effective asthma management, ensuring patients can correctly use their inhalers and achieve optimal therapeutic outcomes.
B: Frequency of rescue inhaler usage. Knowledge about how often a patient uses their rescue inhaler provides critical insight into their asthma control, indicating potential exacerbations or inadequate management strategies.
D: Patient understanding of controllers vs. relievers. Grasping the difference between controller medications and rescue inhalers is essential for long-term asthma management, influencing adherence and overall treatment effectiveness.
Moniliasis of mouth is a complication of inhalation of:
Rationale:
Moniliasis of mouth is a complication of inhalation of Beclomethasone. This corticosteroid can alter the oral flora, leading to an overgrowth of Candida species, resulting in oral thrush or moniliasis.
B: Formoterol This long-acting beta-agonist primarily relaxes airway muscles and does not have a direct association with oral fungal infections.
C: Ipratropium This anticholinergic medication focuses on reducing bronchial secretions and does not contribute to fungal overgrowth in the oral cavity.
D: Nedocromil This mast cell stabilizer is used to prevent asthma symptoms and has no known link to increasing the risk of oral moniliasis.
Side effects of salbutamol include which of the following:
Rationale:
Tachycardia. Salbutamol, a bronchodilator, stimulates beta-adrenergic receptors, leading to an increase in heart rate, which manifests as tachycardia. This side effect is particularly notable in patients using higher doses or with pre-existing heart conditions.
B: Bradycardia. Salbutamol does not induce bradycardia; rather, it typically causes an increased heart rate, not a decrease, making this option incompatible with its known effects.
C: Vomiting. While salbutamol can cause gastrointestinal distress, vomiting is not a prominent or directly linked side effect, limiting its relevance in this context.
D: CNS depression. Salbutamol primarily acts on the respiratory system and does not produce central nervous system depression, contrasting sharply with medications that directly affect brain function.
Hâ‚ antihistaminics are beneficial in
Rationale:
H1 antihistaminics are beneficial in certain type I allergic reactions only. H1 antihistaminics specifically target histamine receptors involved in immediate hypersensitivity reactions, effectively alleviating symptoms associated with type I allergies like hay fever and urticaria.
A: All types of allergic disorders. H1 antihistaminics are not effective for all allergies, particularly those that involve different immune mechanisms or require other treatments like corticosteroids.
C: Anaphylactic shock. H1 antihistaminics alone cannot manage anaphylaxis, which requires immediate emergency interventions such as epinephrine to counteract severe, life-threatening reactions.
D: Bronchial asthma. While antihistaminics may provide some relief, they do not address the underlying bronchial inflammation and airway constriction characteristic of asthma, necessitating different therapeutic approaches.
A COPD patient is being discharged and the doctor wants to prescribe a controller-type bronchodilator for home use. Which of the following would you recommend?
Rationale:
D: Brovana is the recommended controller-type bronchodilator for COPD patients, as it is a long-acting beta-agonist (LABA) that provides sustained relief from bronchoconstriction, improving overall lung function and patient comfort.
A: Albuterol is a short-acting beta-agonist (SABA), primarily used for quick relief rather than long-term control, making it unsuitable as a chronic management option for COPD patients.
B: Levalbuterol, also a SABA, offers rapid symptom relief but lacks the prolonged effects needed for effective maintenance therapy in COPD, thus not meeting the criteria for a controller medication.
C: Metaproterenol, while a bronchodilator, is less commonly used and may not provide the sustained action necessary for effective management of COPD symptoms compared to the preferred long-acting options.
A patient with fluid overload was just given a dose of furosemide via IV. Afterwards, the patient displayed an arrhythmia on the EKG that was not there before the dose was given. Which of the following would you recommend at this time?
Rationale:
Check the patient's potassium level. Monitoring potassium is crucial after administering furosemide as it can lead to electrolyte imbalances, particularly hypokalemia, which may cause or exacerbate arrhythmias.
A: Defibrillate the patient. Immediate defibrillation is only necessary for life-threatening arrhythmias, and there is no indication that this patient is in such a critical state.
B: Administer another dose of furosemide. Giving more furosemide may worsen electrolyte imbalances and potentially aggravate the patient's arrhythmia rather than address the underlying issue.
C: Administer a dose of epinephrine. Epinephrine is typically used in cases of anaphylaxis or cardiac arrest, not for managing arrhythmias related to fluid overload or diuretic use.
While assessing a 72-year-old postoperative patient, you noted distinct wheezing in both lung fields. Which of the following would recommend for this condition?
Rationale:
Give the patient a bronchodilator. Bronchodilators are effective for relieving wheezing by relaxing airway muscles, improving airflow, and reducing bronchospasm, which is crucial in a postoperative patient experiencing respiratory distress.
B: Administer incentive spirometry. While incentive spirometry encourages deep breathing and lung expansion, it does not directly address airway constriction or wheezing, making it less suitable for immediate relief.
C: Give the patient a mucolytic agent. Mucolytics help thin mucus but do not target bronchospasm or airway inflammation, thus failing to provide prompt relief from wheezing symptoms in this scenario.
D: Administer chest physiotherapy. Chest physiotherapy aids in mobilizing secretions and improving lung function, yet it does not specifically alleviate the bronchoconstriction that causes wheezing in this patient.
While monitoring a 67-year-old patient that is receiving volume controlled SIMV, you note that the patient has bilateral wheezes upon auscultation with an increased peak pressure. Which of the following would be appropriate for this patient?
Rationale:
Administer their prescribed bronchodilators. Bronchodilators are indicated for wheezing, which suggests bronchospasm or airway constriction. In this case, addressing the wheezing with bronchodilators can help alleviate respiratory distress and improve airflow.
A: Suction the patient's airway. Suctioning may clear secretions but would not address the underlying cause of wheezing or increased peak pressure.
B: Order a stat chest X-ray. A chest X-ray may identify structural issues but would not provide immediate relief for the patient's wheezing or respiratory condition.
C: Check the cuff pressure. While cuff pressure is important for ventilation, it does not directly relate to the presence of wheezing or the need for immediate treatment.
Isoxuprine is used to treat
Rationale:
Isoxuprine is used to treat premature labor. This medication functions as a tocolytic agent, effectively relaxing uterine muscles and helping to delay preterm contractions, thereby supporting fetal development and reducing risks associated with early delivery.
A: Asthma This medication does not target bronchial dilation or inflammation, which are key factors in asthma treatment, thus making it unsuitable for managing this respiratory condition.
B: Severe hypotension Isoxuprine does not serve as a vasopressor or fluid replacement therapy, which are essential in addressing critically low blood pressure scenarios effectively.
C: Nasal congestion This drug does not possess decongestant properties, which are necessary for alleviating symptoms of nasal congestion, and therefore is not applicable for this condition.
One of the following drugs is a useful bronchodilator but not acting via stimulation of Beta adrenoceptors in respiratory smooth muscles:
Rationale:
D: Theophyllin
Theophyllin is a bronchodilator that works by inhibiting phosphodiesterase, leading to increased levels of cyclic AMP within smooth muscle cells. This mechanism differs from beta adrenoceptor stimulation, making it unique in its action.
A: Adrenaline
Adrenaline functions primarily through stimulation of beta adrenoceptors, resulting in bronchodilation. Its mechanism directly involves activating these receptors in respiratory smooth muscle.
B: Isoprenaline
Isoprenaline predominantly acts on beta adrenoceptors, promoting bronchodilation through this pathway. Its therapeutic effect relies on the activation of these specific receptors in the respiratory system.
C: Salbutamol
Salbutamol is a selective beta-2 adrenergic agonist that induces bronchodilation by stimulating beta adrenoceptors in the bronchial smooth muscles, making it reliant on this mechanism.
You are called to administer acetylcysteine to a 66-year-old female patient. This drug can be helpful in treating which of the following conditions?
Rationale:
Mucous plugs can be effectively treated with acetylcysteine, as it acts as a mucolytic agent, breaking down thick mucus and facilitating easier clearance from the airways, thus improving respiratory function.
A: Bronchospasm Acetylcysteine does not directly relax bronchial muscles or alleviate bronchospasm, which typically requires bronchodilators rather than a mucolytic agent for effective treatment.
C: Pleural effusion Acetylcysteine does not target fluid accumulation in the pleural cavity, as its mechanism focuses on mucus breakdown rather than addressing underlying causes of pleural effusion.
D: Pulmonary hypertension Acetylcysteine has no effect on vascular tone or pressure within the pulmonary arteries, which are key factors in managing pulmonary hypertension and require specific vasodilators.
A patient in the ICU is receiving mechanical ventilation but appears to be breathing asynchronously with the ventilator. Which of the following medications would you recommend?
Rationale:
Midazolam (Versed) is the recommended medication for a patient in the ICU experiencing asynchronous breathing with the ventilator. It is a sedative that can help synchronize the patient’s breathing with the ventilator, reducing anxiety and discomfort.
A: Fluoxetine (Prozac) This selective serotonin reuptake inhibitor is primarily used for depression and anxiety disorders, having no role in managing ventilatory asynchrony or improving mechanical ventilation synchronization.
C: Dextroamphetamine (Dexedrine) This stimulant is used to treat attention deficit hyperactivity disorder and narcolepsy, which does not address ventilatory issues or enhance the patient's respiratory coordination with mechanical support.
D: Cisatracurium (Nimbex) As a neuromuscular blocker, it can paralyze respiratory muscles, potentially exacerbating asynchronous breathing and leading to increased reliance on the ventilator without addressing underlying issues.
Which of the following is a nauseate expectorant:
Rationale:
D: Tincture Ipecacuanaha is a known nauseate expectorant that induces vomiting while also promoting mucus clearance from the respiratory tract, making it effective for treating certain respiratory conditions.
A: Acetylcholine primarily functions as a neurotransmitter and does not have any expectorant properties, focusing instead on muscle activation and signal transmission within the nervous system.
B: Pholcodine acts as a cough suppressant, inhibiting the cough reflex rather than promoting mucus clearance, thus differing from the role of an expectorant.
C: Bromhexine serves as a mucolytic agent, helping to thin mucus but lacking the nauseating effects that characterize a nauseate expectorant like Tincture Ipecacuanaha.
The National Institutes of Health (NIH) guidelines for the treatment of asthma recommended institution of routine inhaled corticosteroids when patients are classified as having greater than or equal to which type of asthma?
Rationale:
Patients with mild persistent asthma are recommended to start routine inhaled corticosteroids according to NIH guidelines. This classification signifies a need for daily management to control symptoms effectively and prevent exacerbations.
A: Mild intermittent This classification indicates infrequent symptoms and typically does not require daily medication, making inhaled corticosteroids unnecessary for effective management at this level.
C: Moderate persistent This level of asthma does require treatment, but the NIH guidelines specifically recommend initiating inhaled corticosteroids starting at the mild persistent classification, not moderate.
D: Severe persistent This type indicates significant asthma control issues, but the guidelines specifically mention the initiation point for corticosteroids at the mild persistent level, not severe.
You are called to give an aerosolized breathing treatment with albuterol to a 41-year-old male patient. If the patient's heart rate were to increase during the treatment, that would be a result of which of the following?
Rationale:
Increased heart rate during the albuterol treatment is a result of Beta 1 and Beta 2 receptor activation. Beta 1 receptors, primarily in the heart, directly stimulate heart rate, while Beta 2 receptors can indirectly influence cardiovascular responses.
A: Alpha only. Activation of Alpha receptors primarily affects vascular constriction and does not directly influence heart rate changes in this context.
B: Beta 1 only. While Beta 1 receptors increase heart rate, ignoring the contribution of Beta 2 receptors in this scenario provides an incomplete understanding of the physiological response.
C: Beta 2 only. Although Beta 2 receptors primarily cause bronchodilation, they can also lead to increased heart rate through indirect pathways, necessitating a consideration of both receptor types.
While prescribing the conventional H₠‚ antihistaminics the patient should be advised to avoid
Rationale:
Driving motor vehicles. H1 antihistamines can cause drowsiness, impairing cognitive function and reaction times, making it unsafe for patients to operate vehicles. This caution is essential for preventing accidents and ensuring road safety.
B: Consuming processed cheese. While dietary restrictions may apply to certain medications, processed cheese does not directly interact with antihistamines, making this advice irrelevant.
C: Strenuous physical exertion. Although some patients may feel drowsy, strenuous physical activity does not specifically relate to the effects of H1 antihistamines, leading to unnecessary caution in this scenario.
D: All of the above. This option implies that all listed activities need avoidance, which is excessive since only driving motor vehicles is directly linked to the side effects of H1 antihistamines.
The common and dose related side effect of salbutamol is
Rationale:
Muscle tremor. Salbutamol, a bronchodilator, frequently leads to muscle tremor as a dose-related side effect due to its action on beta-2 adrenergic receptors, which can stimulate skeletal muscle activity and exacerbate tremors.
A: Rise in blood pressure. While salbutamol can influence cardiovascular parameters, a rise in blood pressure is not a common or prominent dose-related side effect associated with its use.
C: Hyperglycaemia. Salbutamol may affect glucose metabolism, but hyperglycaemia is not a typical side effect experienced by most patients at standard therapeutic doses.
D: Central nervous system stimulation. Although salbutamol can have some CNS effects, stimulation is not a common side effect, making it less relevant in typical contexts of usage.
Ipratropium bromide:
Rationale:
Ipratropium bromide causes bronchodilatation because of its antagonistic effects at the cholinergic M₂/M₃ receptors. This mechanism effectively relaxes bronchial smooth muscles, enhancing airflow in patients with respiratory conditions.
A: Is administered intravenously. Ipratropium bromide is typically delivered via inhalation, targeting the lungs directly, rather than through intravenous administration, which is not standard for this medication.
C: Has a more rapid onset of bronchodilatation than beta agonists. Unlike beta agonists that act quickly, ipratropium bromide has a slower onset, making it less effective for immediate bronchodilation.
D: Has a bitter taste. While ipratropium bromide may have a taste, it is primarily administered through inhalation, minimizing taste perception and emphasizing its therapeutic efficacy over sensory properties.
A 64-year-old male patient is receiving an aerosol treatment with acetylcysteine and hypertonic saline via a small volume nebulizer. After only a few minutes, the patient suddenly becomes dyspneic. Which of the following is the most likely cause of this problem is?
Rationale:
Bronchospasm
The patient's sudden dyspnea after aerosol treatment indicates bronchospasm, a common reaction to inhaled irritants like acetylcysteine or hypertonic saline, which can cause airway constriction and difficulty breathing.
A: Hypercapnia Elevated carbon dioxide levels typically develop gradually and are less likely to cause sudden dyspnea compared to immediate airway constriction from bronchospasm following nebulizer treatment.
C: Hypotension This condition generally manifests with symptoms like dizziness or fainting, not acute dyspnea, making it an unlikely cause in the context of recent aerosol therapy.
D: Fluid overload While fluid overload can lead to respiratory distress, it is a gradual process and would not typically cause immediate dyspnea as seen in this scenario.
To be a useful inhaled glucocorticoid the drug should have
Rationale:
To be a useful inhaled glucocorticoid, the drug should have low oral bioavailability. This property ensures that the medication is primarily delivered to the lungs, minimizing systemic side effects and maximizing local therapeutic effects in treating respiratory conditions.
A: High oral bioavailability. A high bioavailability would lead to significant systemic exposure, increasing the risk of side effects and reducing the drug's effectiveness in targeted lung treatment.
C: Additional bronchodilator activity. While beneficial, bronchodilator properties are not essential for glucocorticoids, which primarily focus on reducing inflammation rather than directly dilating airways.
D: Prodrug character. Although prodrugs can enhance delivery, inhaled glucocorticoids typically require immediate activation in the lungs, making this characteristic unnecessary for their intended purpose.
Fluticasone by inhalation is useful in long-term control of bronchial asthma by acting as:
Rationale:
Fluticasone by inhalation is useful in long-term control of bronchial asthma by acting as an anti-inflammatory corticosteroid. This medication reduces airway inflammation, improving breathing and preventing asthma attacks by decreasing the immune response in the lungs.
A: Anti-leukotriene Targets leukotrienes, which contribute to bronchoconstriction and inflammation, but fluticasone primarily reduces inflammation through corticosteroid action, rather than blocking leukotriene effects directly.
B: Anti-histamine Focuses on blocking histamine receptors to alleviate allergy symptoms. Fluticasone's role is not related to histamine but centers on suppressing inflammation in the airways.
D: Mast cell stabilizer Functions by preventing mast cells from releasing mediators that cause inflammation. Fluticasone does not stabilize mast cells; instead, it directly reduces inflammation through corticosteroid mechanisms.
Pulmonary eosinophilia is caused by the following drugs:
Rationale:
Pulmonary eosinophilia is caused by Nitrofurantoin. This drug is known to induce hypersensitivity reactions leading to eosinophilic infiltration in the lungs, presenting symptoms such as cough, dyspnea, and fever in affected individuals.
A: Methysergide This medication primarily targets migraines and does not typically trigger pulmonary eosinophilia, focusing instead on vascular effects without significant respiratory complications.
B: Aspirin Aspirin's primary role is as a pain reliever and anti-inflammatory; it does not induce eosinophilic lung conditions, which are not its recognized adverse effects.
D: Carmustine (BCNU) This chemotherapeutic agent is associated with various side effects but lacks a direct link to pulmonary eosinophilia, as its primary toxicity involves hematological and gastrointestinal systems.